THURSDAY, July 24, 2025 (HealthDay News) — The U.S. Food and Drug Administration (FDA) has upgraded a recall of a commonly prescribed thyroid medication due to what it described as “subpotent” active ingredients. The recall of more than 160,000 bottles of levothyroxine sodium, which went into effect June 20, wasContinue Reading

TUESDAY, March 18, 2025 (HealthDay News) — Gender-affirming hormone therapy may not only help transgender and nonbinary individuals physically — it could also improve their mental health, new research suggests. A study published March 17 in JAMA Network Open found that transgender, nonbinary and gender-diverse people who were prescribed hormoneContinue Reading